{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:10:14Z","timestamp":1779354614245,"version":"3.51.4"},"reference-count":53,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/cahx3621","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:53:17Z","timestamp":1777348397000},"page":"2977-2987","source":"Crossref","is-referenced-by-count":0,"title":["Bidirectional causal relationship between rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization study"],"prefix":"10.62347","volume":"18","author":[{"given":"Weijie","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"102743","DOI":"10.1016\/j.autrev.2020.102743","article-title":"An updated advance of autoantibodies in autoimmune diseases","volume":"20","author":"ZX","year":"2021","unstructured":"Xiao ZX, Miller JS and Zheng SG. An updated advance of autoantibodies in autoimmune diseases. Autoimmun Rev 2021; 20: 102743.","journal-title":"Autoimmun Rev"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1080310","DOI":"10.3389\/fimmu.2023.1080310","article-title":"Macrophage: key player in the pathogenesis of autoimmune diseases","volume":"14","author":"Yang","year":"2023","unstructured":"Yang S, Zhao M and Jia S. Macrophage: key player in the pathogenesis of autoimmune diseases. Front Immunol 2023; 14: 1080310.","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","unstructured":"Pisetsky DS. Pathogenesis of autoimmune disease. Nat Rev Nephrol 2023; 19: 509-524.","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.autrev.2021.102925","article-title":"Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus","volume":"21","author":"Restivo","year":"2022","unstructured":"Restivo V, Candiloro S, Daidone M, Norrito R, Cataldi M, Minutolo G, Caracci F, Fasano S, Ciccia F, Casuccio A and Tuttolomondo A. Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus. Autoimmun Rev 2022; 21: 102925.","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y and Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 2023; 82: 351-356.","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.molmed.2020.09.009","article-title":"Leveraging heterogeneity in systemic lupus erythematosus for new therapies","volume":"27","author":"ME","year":"2021","unstructured":"Allen ME, Rus V and Szeto GL. Leveraging heterogeneity in systemic lupus erythematosus for new therapies. Trends Mol Med 2021; 27: 152-171.","journal-title":"Trends Mol Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-014-0428-6","article-title":"The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved","volume":"36","author":"Rekvig","year":"2014","unstructured":"Rekvig OP and Van der Vlag J. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin Immunopathol 2014; 36: 301-311.","journal-title":"Semin Immunopathol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","unstructured":"Weyand CM and Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol 2021; 22: 10-18.","journal-title":"Nat Immunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","unstructured":"McInnes IB and Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-2219.","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2013.161","article-title":"Clinical implications of shared genetics and pathogenesis in autoimmune diseases","volume":"9","author":"Zhernakova","year":"2013","unstructured":"Zhernakova A, Withoff S and Wijmenga C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol 2013; 9: 646-659.","journal-title":"Nat Rev Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.7326\/0003-4819-97-5-659","article-title":"Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis","volume":"97","author":"Chalmers","year":"1982","unstructured":"Chalmers A, Thompson D, Stein HE, Reid G and Patterson AC. Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis. Ann Intern Med 1982; 97: 659-663.","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/BF02242956","article-title":"Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus","volume":"13","author":"Borg","year":"1994","unstructured":"Borg AA, Davis MJ, Dawes PT and Shadforth MF. Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus. Clin Rheumatol 1994; 13: 522-524.","journal-title":"Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ehb.2013.12.002","article-title":"Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates","volume":"13","author":"AE","year":"2014","unstructured":"Taylor AE, Davies NM, Ware JJ, VanderWeele T, Smith GD and Munafò MR. Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates. Econ Hum Biol 2014; 13: 99-106.","journal-title":"Econ Hum Biol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JAC, Timpson N and Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008; 27: 1133-1163.","journal-title":"Stat Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41588-018-0192-y","article-title":"Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk","volume":"50","author":"Castel","year":"2018","unstructured":"Castel SE, Cervera A, Mohammadi P, Aguet F, Reverter F, Wolman A, Guigo R, Iossifov I, Vasileva A and Lappalainen T. Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk. Nat Genet 2018; 50: 1327-1334.","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000321179","article-title":"An introduction to instrumental variables--part 2: mendelian randomisation","volume":"35","author":"Bennett","year":"2010","unstructured":"Bennett DA. An introduction to instrumental variables--part 2: mendelian randomisation. Neuroepidemiology 2010; 35: 307-310.","journal-title":"Neuroepidemiology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/ndt\/gfq098","article-title":"Mendelian randomization: use of genetics to enable causal inference in observational studies","volume":"25","author":"Verduijn","year":"2010","unstructured":"Verduijn M, Siegerink B, Jager KJ, Zoccali C and Dekker FW. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant 2010; 25: 1394-1398.","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev-genom-090314-050016","article-title":"Mendelian randomization: new applications in the coming age of hypothesis-free causality","volume":"16","author":"Evans","year":"2015","unstructured":"Evans DM and Davey Smith G. Mendelian randomization: new applications in the coming age of hypothesis-free causality. Annu Rev Genomics Hum Genet 2015; 16: 327-350.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators","volume":"178","author":"Pierce","year":"2013","unstructured":"Pierce BL and Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 2013; 178: 1177-1184.","journal-title":"Am J Epidemiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"746998","DOI":"10.3389\/fimmu.2021.746998","article-title":"Causal relationship between gut microbiota and autoimmune diseases: a two-sample Mendelian randomization study","volume":"12","author":"Xu","year":"2022","unstructured":"Xu Q, Ni JJ, Han BX, Yan SS, Wei XT, Feng GJ, Zhang H, Zhang L, Li B and Pei YF. Causal relationship between gut microbiota and autoimmune diseases: a two-sample Mendelian randomization study. Front Immunol 2022; 12: 746998.","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/rheumatology\/keaa506","article-title":"Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study","volume":"60","author":"Dan","year":"2021","unstructured":"Dan YL, Wang P, Cheng Z, Wu Q, Wang XR, Wang DG and Pan HF. Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study. Rheumatology (Oxford) 2021; 60: 940-946.","journal-title":"Rheumatology (Oxford)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","unstructured":"Burgess S and Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 2017; 32: 377-389.","journal-title":"Eur J Epidemiol"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F and Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11: 193-206.","DOI":"10.1037\/1082-989X.11.2.193"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamacardio.2019.4281","article-title":"Heterogeneity between genetic variants as a proxy for pleiotropy in Mendelian randomization","volume":"5","author":"Gill","year":"2020","unstructured":"Gill D. Heterogeneity between genetic variants as a proxy for pleiotropy in Mendelian randomization. JAMA Cardiol 2020; 5: 107-108.","journal-title":"JAMA Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Mokry LE, Ross S, Timpson NJ, Sawcer S, Davey Smith G and Richards JB. Obesity and multiple sclerosis: a Mendelian randomization study. PLoS Med 2016; 13: e1002053.","DOI":"10.1371\/journal.pmed.1002053"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B and Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50: 693-698.","journal-title":"Nat Genet"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM and Okosieme OE. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 2018; 14: 301-316.","journal-title":"Nat Rev Endocrinol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.berh.2018.09.004","article-title":"Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus","volume":"32","author":"Gergianaki","year":"2018","unstructured":"Gergianaki I, Bortoluzzi A and Bertsias G. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2018; 32: 188-205.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/1744666X.2022.2106970","article-title":"Epidemiology of rheumatoid arthritis: genetic and environmental influences","volume":"18","author":"Venetsanopoulou","year":"2022","unstructured":"Venetsanopoulou AI, Alamanos Y, Voulgari PV and Drosos AA. Epidemiology of rheumatoid arthritis: genetic and environmental influences. Expert Rev Clin Immunol 2022; 18: 923-931.","journal-title":"Expert Rev Clin Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13075-021-02547-2","article-title":"Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study","volume":"23","author":"Miyazaki","year":"2021","unstructured":"Miyazaki Y, Nakano K, Nakayamada S, Kubo S, Iwata S, Hanami K, Fukuyo S, Miyagawa I, Yamaguchi A, Kawabe A, Saito K and Tanaka Y. Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study. Arthritis Res Ther 2021; 23: 154.","journal-title":"Arthritis Res Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1002\/art.34483","article-title":"Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus","volume":"64","author":"Weckerle","year":"2012","unstructured":"Weckerle CE, Mangale D, Franek BS, Kelly JA, Kumabe M, James JA, Moser KL, Harley JB and Niewold TB. Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2947-2952.","journal-title":"Arthritis Rheum"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1136\/ard.2008.097642","article-title":"STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk","volume":"68","author":"AK","year":"2009","unstructured":"Abelson AK, Delgado-Vega AM, Kozyrev SV, Sánchez E, Velázquez-Cruz R, Eriksson N, Wojcik J, Linga Reddy MV, Lima G, D’Alfonso S, Migliaresi S, Baca V, Orozco L, Witte T, Ortego-Centeno N, Abderrahim H, Pons-Estel BA, Gutiérrez C, Suárez A, González-Escribano MF, Martin J and Alarcón-Riquelme ME. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis 2009; 68: 1746-1753.","journal-title":"Ann Rheum Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"8830","DOI":"10.1038\/s41598-020-63757-3","article-title":"Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease course","volume":"10","author":"Seyhan","year":"2020","unstructured":"Seyhan AA, Gregory B, Cribbs AP, Bhalara S, Li Y, Loreth C, Zhang Y, Guo Y, Lin LL, Feldmann M, Williams LM, Brennan FM and Taylor PC. Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease course. Sci Rep 2020; 10: 8830.","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.4049\/jimmunol.164.9.4659","article-title":"Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation","volume":"164","author":"DM","year":"2000","unstructured":"Frucht DM, Aringer M, Galon J, Danning C, Brown M, Fan S, Centola M, Wu CY, Yamada N, El Gabalawy H and O’Shea JJ. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J Immunol 2000; 164: 4659-4664.","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.autrev.2012.09.004","article-title":"Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients","volume":"12","author":"Tani","year":"2013","unstructured":"Tani C, D’Aniello D, Delle Sedie A, Carli L, Cagnoni M, Possemato N, Carbone M, Della Rossa A, Riente L, Baldini C, Talarico R, Caramella D, Bombardieri S and Mosca M. Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev 2013; 12: 537-541.","journal-title":"Autoimmun Rev"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12951-023-01857-8","article-title":"Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments","volume":"21","author":"Chi","year":"2023","unstructured":"Chi XK, Xu XL, Chen BY, Su J and Du YZ. Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments. J Nanobiotechnology 2023; 21: 105.","journal-title":"J Nanobiotechnology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/ard.46.11.853","article-title":"Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases","volume":"46","author":"Cohen","year":"1987","unstructured":"Cohen MG and Webb J. Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. Ann Rheum Dis 1987; 46: 853-858.","journal-title":"Ann Rheum Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"102612","DOI":"10.1016\/j.autrev.2020.102612","article-title":"Rhupus: a systematic literature review","volume":"19","author":"Antonini","year":"2020","unstructured":"Antonini L, Le Mauff B, Marcelli C, Aouba A and de Boysson H. Rhupus: a systematic literature review. Autoimmun Rev 2020; 19: 102612.","journal-title":"Autoimmun Rev"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","unstructured":"Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, de Bakker PIW, Le JM, Lee HS, Batliwalla F, Li W, Masters SL, Booty MG, Carulli JP, Padyukov L, Alfredsson L, Klareskog L, Chen WV, Amos CI, Criswell LA, Seldin MF, Kastner DL and Gregersen PK. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007; 357: 977-986.","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/annrheumdis-2016-209436","article-title":"A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus","volume":"76","author":"M&#xE1","year":"2017","unstructured":"Márquez A, Vidal-Bralo L, Rodríguez-Rodríguez L, González-Gay MA, Balsa A, González-Álvaro I, Carreira P, Ortego-Centeno N, Ayala-Gutiérrez MM, García-Hernández FJ, González-Escribano MF, Sabio JM, Tolosa C, Suárez A, González A, Padyukov L, Worthington J, Vyse T, Alarcón-Riquelme ME and Martín J. A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 2017; 76: 286-294.","journal-title":"Ann Rheum Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00281-014-0440-x","article-title":"Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus","volume":"36","author":"Marion","year":"2014","unstructured":"Marion TN and Postlethwaite AE. Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus. Semin Immunopathol 2014; 36: 495-517.","journal-title":"Semin Immunopathol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.autrev.2018.06.001","article-title":"Mechanistic immunological based classification of rheumatoid arthritis","volume":"17","author":"McGonagle","year":"2018","unstructured":"McGonagle D, Watad A and Savic S. Mechanistic immunological based classification of rheumatoid arthritis. Autoimmun Rev 2018; 17: 1115-1123.","journal-title":"Autoimmun Rev"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/ard.2010.137174","article-title":"Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus","volume":"70","author":"Orozco","year":"2011","unstructured":"Orozco G, Eyre S, Hinks A, Bowes J, Morgan AW, Wilson AG, Wordsworth P, Steer S, Hocking L, consortium U, Thomson W, Worthington J and Barton A. Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 2011; 70: 463-468.","journal-title":"Ann Rheum Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/jdv.12435","article-title":"Relationship between the IL-4 gene promoter -590C\/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: a meta-analysis","volume":"29","author":"Qiu","year":"2015","unstructured":"Qiu LJ, Ni J, Cen H, Wen PF, Zhang M, Liang Y, Pan HF, Mao C and Ye DQ. Relationship between the IL-4 gene promoter -590C\/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: a meta-analysis. J Eur Acad Dermatol Venereol 2015; 29: 48-55.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10787-025-02073-6","article-title":"Molecular mechanisms and risk factors in rheumatoid arthritis: a comprehensive review","volume":"34","author":"Kumar","year":"2026","unstructured":"Kumar A, Singh S, Goel F, Pandey RK, Singh L, Kumar A and Dobhal V. Molecular mechanisms and risk factors in rheumatoid arthritis: a comprehensive review. Inflammopharmacology 2026; 34: 125-144.","journal-title":"Inflammopharmacology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"103648","DOI":"10.1016\/j.autrev.2024.103648","article-title":"Immunopathogenesis of systemic lupus erythematosus: an update","volume":"23","author":"Arnaud","year":"2024","unstructured":"Arnaud L, Chasset F and Martin T. Immunopathogenesis of systemic lupus erythematosus: an update. Autoimmun Rev 2024; 23: 103648.","journal-title":"Autoimmun Rev"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Kumar M, Yip L, Wang F, Marty SE and Fathman CG. Autoimmune disease: genetic susceptibility, environmental triggers, and immune dysregulation. Where can we develop therapies? Front Immunol 2025; 16: 1626082.","DOI":"10.3389\/fimmu.2025.1626082"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1080\/1744666X.2025.2605662","article-title":"Rhupus syndrome: current knowledge and future perspectives","volume":"21","author":"Amezcua-Guerra LM","year":"2025","unstructured":"Amezcua-Guerra LM, Roldán-Ortega J and Mora-Ramírez M. Rhupus syndrome: current knowledge and future perspectives. Expert Rev Clin Immunol 2025; 21: 1709-1724.","journal-title":"Expert Rev Clin Immunol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jaip.2023.04.018","article-title":"Inborn errors of immunity and autoimmune disease","volume":"11","author":"Gray","year":"2023","unstructured":"Gray PE and David C. Inborn errors of immunity and autoimmune disease. J Allergy Clin Immunol Pract 2023; 11: 1602-1622.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data","volume":"27","author":"Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C and Köttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol 2016; 27: 3253-3265.","journal-title":"J Am Soc Nephrol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10067-024-07046-8","article-title":"Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients","volume":"43","author":"Liu","year":"2024","unstructured":"Liu M, Wang S, Liang Y, Fan Y and Wang W. Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients. Clin Rheumatol 2024; 43: 2403-2416.","journal-title":"Clin Rheumatol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","unstructured":"Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE and Ramsey-Goldman R. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 2021; 17: 515-532.","journal-title":"Nat Rev Rheumatol"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Zhong H, Li XL, Li M, Hao LX, Chen RW, Xiang K, Qi XB, Ma RZ and Su B. Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res Ther 2011; 13: R186.","DOI":"10.1186\/ar3514"}],"container-title":["American Journal of Translational Research"],"original-title":[],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:38:36Z","timestamp":1779352716000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/18\/4\/ajtr0171411.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.62347\/cahx3621","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}